Library / Laws / 119th Congress / House Bills / H.R. 1051
H.R. 1051
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2025-02-06 | 5.2K | ⠃⠗⠋ |